[39] likewise found significantly lower rates of CSF shunt procedures in the GLP-1 RA group (exenatide, lixisenatide, semaglutide, dulaglutide, liraglutide, tirzepatide, albiglutide) compared to controls ( 1.8% vs
This medicine may harm your baby
Both the Kidney Disease Improving Global Outcomes guidelines and American Diabetes Association Standards of Care recommend GLP1-RA as the preferred glucose lowering class for people with T2D and moderate to advanced CKD or ESRD because of their demonstrated cardiovascular benefits in people with T2D at high risk of cardiovascular disease, which includes CKD 13,14
It's an active area of research interest because dihexa promotes new synaptic connections, but it is not a proven or approved treatment for cognitive decline
Multi-pack pricing available